Integrated aqueous shunt for glaucoma treatment
US11406533B2 · kind B2 · utility
2Cited by
103References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 15, 2018 |
| Grant date | Aug 9, 2022 |
| Priority date | — |
| Expiry date | Mar 29, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M2210/0612
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
Glaucoma treatment devices are disclosed. In various example, the glaucoma treatment devices include multiple microporous layers arranged together to form a microporous body configured to help facilitate evacuation of fluid from a fluid-filled body cavity, and reabsorption of the evacuated aqueous humor by the body through tissue surrounding the glaucoma treatment device. In some examples, the glaucoma treatment device includes one or more portions configured to resist cellular ingrowth, and one or more portions configured to permit cellular ingrowth.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.